Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY25.73 CNY
Change Today +0.43 / 1.70%
Volume 7.7M
300009 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 03/31/15 All times are local (Market data is delayed by at least 15 minutes).

anhui anke biotechnology g-a (300009) Snapshot

Open
CNY25.25
Previous Close
CNY25.30
Day High
CNY26.18
Day Low
CNY24.97
52 Week High
03/24/15 - CNY27.35
52 Week Low
06/19/14 - CNY12.65
Market Cap
7.5B
Average Volume 10 Days
9.8M
EPS TTM
CNY0.38
Shares Outstanding
290.4M
EX-Date
--
P/E TM
68.5x
Dividend
CNY0.15
Dividend Yield
0.65%
Current Stock Chart for ANHUI ANKE BIOTECHNOLOGY G-A (300009)

Related News

No related news articles were found.

anhui anke biotechnology g-a (300009) Related Businessweek News

No Related Businessweek News Found

anhui anke biotechnology g-a (300009) Details

Anhui Anke Biotechnology (Group) Co., Ltd., together with its subsidiaries, develops, manufactures, and markets pharmaceuticals and health-care products in China and internationally. It offers recombinant human interferon alpha 2b for injection, interferon alpha 2b creams, interferon alpha 2b eye drops, and interferon alpha 2b suppository under the Anterferon name; and recombinant human growth hormone/somatropin for injection under the Ansomone name. The company also provides monoclonal antibody affinity gel to a-interferon; diagnostic kits; and adefovir dipivoxil tablets, an anti-virus medicine for oral administration. In addition, it offers traditional Chinese medicine and synthetic drugs, including dispersible tablets, adhesive plasters, oral liquids, ointments, granulation, capsules, tinctures, plasters, syrups, powders, and others. The company is based in Hefei, China.

anhui anke biotechnology g-a (300009) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

anhui anke biotechnology g-a (300009) Key Developments

Anhui Anke Biotechnology (Group) Co., Ltd. Approves Amendments to the Articles of Association

Anhui Anke Biotechnology (Group) Co., Ltd. approved amendments to the articles of association of the company, at the annual general meeting held on March 25, 2015.

Anhui Anke Biotechnology (Group) Co., Ltd. Approves Cash Dividend for 2014

Anhui Anke Biotechnology (Group) Co., Ltd. announced that at the AGM held on March 25, 2015, the shareholders approved cash dividend of CNY 1.500 (tax include) per 10 shares for 2014.

Anhui Anke Biotechnology (Group) Co., Ltd., 2014 Earnings Call, Mar 17, 2015

Anhui Anke Biotechnology (Group) Co., Ltd., 2014 Earnings Call, Mar 17, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300009:CH CNY25.73 CNY +0.43

300009 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300009.
View Industry Companies
 

Industry Analysis

300009

Industry Average

Valuation 300009 Industry Range
Price/Earnings 67.7x
Price/Sales 13.5x
Price/Book 10.1x
Price/Cash Flow 68.0x
TEV/Sales 13.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ANHUI ANKE BIOTECHNOLOGY G-A, please visit www.ankebio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.